{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:18:57Z","timestamp":1789993137579,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.tracli.2017.06.014","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T20:01:06Z","timestamp":1498852866000},"page":"189-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Occult hepatitis B infection and transfusion-transmission risk"],"prefix":"10.1016","volume":"24","author":[{"given":"D.","family":"Candotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Boizeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Laperche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2017.06.014_bib0195","series-title":"Hepatitis B Fact sheet","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.tracli.2017.06.014_bib0200","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2008.07.014","article-title":"Statements from the Taormina expert meeting on occult hepatitis B virus infection","volume":"49","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.tracli.2017.06.014_bib0205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1423-0410.2011.01506.x","article-title":"International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009","volume":"102","author":"Roth","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2017.06.014_bib0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1537-2995.2007.01482.x","article-title":"Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006","volume":"48","author":"Polizzotto","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/trf.13298","article-title":"Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors","volume":"56","author":"Slot","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcv.2017.02.001","article-title":"Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples","volume":"89","author":"Thibault","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.tracli.2017.06.014_bib0225","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1128\/JCM.02117-15","article-title":"Comparative performance of three rapid HBsAg assays for detection of HBs diagnostic escape mutants in clinical samples","volume":"53","author":"Servant-Delmas","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tracli.2017.06.014_bib0230","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/trf.12962","article-title":"The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country","volume":"55","author":"van de Laar","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0235","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1537-2995.2012.03909.x","article-title":"Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan","volume":"53","author":"Taira","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/trf.13819","article-title":"Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing","volume":"57","author":"Lelie","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0245","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1537-2995.2011.03355.x","article-title":"Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk","volume":"52","author":"Vermeulen","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0250","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1537-2995.2008.01701.x","article-title":"Hepatitis B virus infection and transfusion medicine: science and the occult","volume":"48","author":"Hollinger","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0255","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.23886","article-title":"Impact of HBV surface protein mutations on the diagnosis of occult HBV infection","volume":"52","author":"El Chaar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.tracli.2017.06.014_bib0260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jcv.2013.06.020","article-title":"HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient","volume":"58","author":"Coppola","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.tracli.2017.06.014_bib0265","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/trf.12653","article-title":"Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV markers results from United States blood donors","volume":"54","author":"Enjalbert","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0270","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jhep.2015.06.016","article-title":"Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy","volume":"63","author":"Spreafico","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.tracli.2017.06.014_bib0275","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/trf.12556","article-title":"Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection","volume":"54","author":"Kiely","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0280","first-page":"174","article-title":"Diagnostic algorithm for HBV safe transfusion","volume":"7","author":"Allain","year":"2009","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2017.06.014_bib0285","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1423-0410.2012.01662.x","article-title":"Component pathogen inactivation: a critical review","volume":"104","author":"Prowse","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2017.06.014_bib0290","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/trf.14050","article-title":"A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios","volume":"57","author":"Weusten","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0295","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1007644","article-title":"Nucleic acid testing to detect HBV infection in blood donors","volume":"364","author":"Stramer","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2017.06.014_bib0300","first-page":"15","article-title":"The clinical significance of occult HBV infection","volume":"27","author":"Squadrito","year":"2014","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.tracli.2017.06.014_bib0305","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/hep.22879","article-title":"Characterization of occult hepatitis B virus strains in South African blood donors","volume":"49","author":"Allain","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.tracli.2017.06.014_bib0310","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jhep.2008.04.017","article-title":"Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains","volume":"49","author":"Candotti","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.tracli.2017.06.014_bib0315","doi-asserted-by":"crossref","first-page":"7882","DOI":"10.1128\/JVI.00710-13","article-title":"Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection","volume":"87","author":"Biswas","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.tracli.2017.06.014_bib0320","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4254\/wjh.v6.i6.384","article-title":"Clinical impact of occult hepatitis B virus infection in immunosuppressed patients","volume":"27","author":"Sagnelli","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.tracli.2017.06.014_bib0325","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/gutjnl-2011-301281","article-title":"Occult hepatitis B infection in blood donors from South East Asia: molecular characterization and potential mechanisms of occurrence","volume":"61","author":"Candotti","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.tracli.2017.06.014_bib0330","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.00018-11","article-title":"Molecular mechanisms underlying occult hepatitis B virus infection","volume":"25","author":"Samal","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tracli.2017.06.014_bib0335","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2009.05.020","article-title":"Transfusion-transmitted hepatitis B virus infection","volume":"51","author":"Candotti","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.tracli.2017.06.014_bib0340","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-3148.2010.01036.x","article-title":"The clinical significance of occult hepatitis B transfusion in Taiwan \u2013\u00a0a look back study","volume":"21","author":"Su","year":"2010","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2017.06.014_bib0345","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1046\/j.1537-2995.2002.00274.x","article-title":"Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers","volume":"42","author":"Wang","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0350","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/trf.12096","article-title":"Infectivity of blood products from donors with occult hepatitis B virus infection","volume":"53","author":"Allain","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/vox.12198","article-title":"Infectivity of blood components from donors with occult hepatitis B infection \u2013\u00a0results from an Australian lookback programme","volume":"108","author":"Seed","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2017.06.014_bib0360","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/cid\/ciq247","article-title":"Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection","volume":"52","author":"Yuen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tracli.2017.06.014_bib0365","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1537-2995.2007.01276.x","article-title":"Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program","volume":"47","author":"Satake","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0370","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/trf.13401","article-title":"Rare transmission of hepatitis B virus by Dutch donors with occult infection","volume":"56","author":"Lieshout-Krikke","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.014_bib0375","first-page":"146","article-title":"Transmission of occult HBV infection by ID-NAT screened blood","volume":"107","author":"Vermeulen","year":"2014","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2017.06.014_bib0380","first-page":"147","article-title":"Fresh-frozen plasma from an anti-HBc positive donor with undetectable HBV DNA transmitted hepatitis B virus to two recipients","volume":"107","author":"Levicnic-Stezinar","year":"2014","journal-title":"Vox Sang"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:37:08Z","timestamp":1761129428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782017300952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1246782017300952"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2017.06.014","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occult hepatitis B infection and transfusion-transmission risk","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2017.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}